Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994 to 2012

Journal of Pediatrics

Volumn 165, Issue 6, 2014, Pages 1091-1097.e2

  Vandevanter, Donald R ^a   Pasta, David J ^b   Konstan, Michael W ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ICON CLINICAL RESEARCH   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY HEIGHT; CHILD; COHORT ANALYSIS; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE MUTATION; GENOTYPE; HEALTH INSURANCE; HUMAN; KOLMOGOROV SMIRNOV TEST; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAID; NEWBORN SCREENING; PRESCHOOL CHILD; REGISTER; SEX DIFFERENCE; SPIROMETRY; LONGITUDINAL STUDY; LUNG; NEWBORN; PATHOPHYSIOLOGY; VITAL CAPACITY;

BODY HEIGHT; CHILD; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFANT, NEWBORN; LONGITUDINAL STUDIES; LUNG; MALE; NEONATAL SCREENING; SPIROMETRY; VITAL CAPACITY;

EID: 84912523010     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.06.061     Document Type: Article

References (22)

1. P.B. Davis, M. Drumm, and M.W. Konstan Cystic fibrosis Am J Respir Crit Care Med 154 1996 1229 1256
2. J.F. Chmiel, M. Berger, and M.W. Konstan The role of inflammation in the pathophysiology of CF lung disease Clin Rev Allergy Immunol 23 2002 5 27
3. C. Johnson, S.M. Butler, M.W. Konstan, W. Morgan, and M.E. Wohl Factors influencing outcomes in cystic fibrosis: a center-based analysis Chest 123 2003 20 27
4. M.W. Konstan, D.R. VanDevanter, L. Rasouliyan, D.J. Pasta, A. Yegin, and W.J. Morgan Trends in the use of routine therapies in cystic fibrosis: 1995-2005 Pediatr Pulmonol 45 2010 1167 1172
5. D.R. VanDevanter, and M.W. Konstan Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease Clin Invest 2 2012 163 175
6. M.D. Schluchter, M.W. Konstan, M.L. Drumm, J.R. Yankaskas, and M.R. Knowles Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data Am J Respir Crit Care Med 174 2006 780 786
7. M.W. Konstan, J.S. Wagener, and D.R. VanDevanter Characterizing aggressiveness and predicting future progression of CF lung disease J Cyst Fibros 8 Suppl 1 2009 S15 S19
8. Cystic Fibrosis Foundation Patient Registry 2012 Annual data report to the center directors 2013 Cystic Fibrosis Foundation Bethesda (MD)
9. S.D. Grosse, C.A. Boyle, J.R. Botkin, A.M. Comeau, M. Kharrazi, and M. Rosenfeld Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs MMWR Recomm Rep 53 2004 1 36
10. P.D. Sly, S. Brennan, C. Gangell, N. de Klerk, C. Murray, and L. Mott Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening Am J Respir Crit Care Med 180 2009 146 152
11. S.M. Stick, S. Brennan, C. Murray, T. Douglas, B.S. von Ungern-Sternberg, and L.W. Garratt Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening J Pediatr 155 2009 623 628
12. G.L. Hall, K.M. Logie, F. Parsons, S.M. Schulzke, G. Nolan, and C. Murray Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening PLoS One 6 2011 e23932
13. A.F. Hoo, L.P. Thia, T.T. Nguyen, A. Bush, J. Chudleigh, and S. Lum Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening Thorax 67 2012 874 881
14. L.S. Mott, J. Park, C.P. Murray, C.L. Gangell, N.H. de Klerk, and P.J. Robinson Progression of early structural lung disease in young children with cystic fibrosis assessed using CT Thorax 67 2012 509 516
15. X. Wang, D.W. Dockery, D. Wypij, M.E. Fay, and B.G. Ferris Jr. Pulmonary function between 6 and 18 years of age Pediatr Pulmonol 15 1993 75 88
16. P.H. Quanjer, S. Stanojevic, T.J. Cole, X. Baur, G.L. Hall, and B.H. Culver Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations Eur Respir J 40 2012 1324 1343
17. G.T. O'Connor, H.B. Quinton, R. Kahn, P. Robichaud, J. Maddock, and T. Lever Case-mix adjustment for evaluation of mortality in cystic fibrosis Pediatr Pulmonol 33 2002 99 105
18. S. Stanojevic, J. Stocks, V. Bountziouka, P. Aurora, J. Kirkby, and S. Bourke The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF Registry J Cyst Fibros 13 2014 319 327
19. M.W. Konstan, S.M. Butler, M.E. Wohl, M. Stoddard, R. Matousek, and J.S. Wagener Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis J Pediatr 142 2003 624 630
20. P.H. Quanjer, and D.J. Weiner Interpretative consequences of adopting the Global Lungs 2012 reference equations for spirometry for children and adolescents Pediatr Pulmonol 49 2014 118 125
21. R.J. Adam, A.S. Michalski, C. Bauer, M.H. Abou Alaiwa, T.J. Gross, and M.S. Awadalla Air-trapping and airflow obstruction in newborn cystic fibrosis piglets Am J Respir Crit Care Med 188 2013 1434 1441
22. Cystic Fibrosis Foundation, D. Borowitz, K.A. Robinson, M. Rosenfeld, S.D. Davis, and K.A. Sabadosa Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis J Pediatr 155 2009 S73 S93